- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Berman named CEO of Lumisys
Lumisys president Philip Berman has added the title of CEO, assuming that post from chairman Douglas DeVivo. Berman, who came to Lumisys in November when the company acquired CompuRad, will spearhead the company's entrée into the computed
Lumisys president Philip Berman has added the title of CEO, assuming that post from chairman Douglas DeVivo. Berman, who came to Lumisys in November when the company acquired CompuRad, will spearhead the company's entrée into the computed radiography market (SCAN 5/13/98).
Berman's appointment comes soon after other management moves by the company. COO and CFO Craig Klosterman has left the company to join Informatica, a private software company. Replacing Klosterman as CFO is vice president of finance Dean MacIntosh. Also, the company has hired Duncan Moffat for the newly created post of vice president of operations.
In other Lumisys news, the company has begun a road show to commemorate the launch of its ACR-2000 desktop computed radiography unit, which Lumisys plans to sell through the same network of OEMs that market its film digitizers. Vice president of channel development and sales Scott Evers is traveling around the U.S. in a new yellow Volkswagen Beetle to demonstrate the unit to clinics, hospitals, OEMs, VARs, and systems integrators. The trip will conclude at this year's Radiological Society of North America meeting, with commercial deliveries expected to begin in early 1999.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
